SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004549
Filing Date
2019-04-01
Accepted
2019-04-01 16:42:28
Documents
74
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1178828
2 image_001.jpg GRAPHIC 635
3 image_002.jpg GRAPHIC 113625
4 image_003.jpg GRAPHIC 69442
5 image_004.jpg GRAPHIC 29112
6 image_005.jpg GRAPHIC 72422
7 image_006.jpg GRAPHIC 39891
8 image_007.jpg GRAPHIC 144620
9 image_008.jpg GRAPHIC 82235
10 image_009.jpg GRAPHIC 645
11 ex10-26.htm EX-10.26 79885
12 ex23-1.htm EX-23.1 4086
13 ex31.htm EX-31 36444
14 ex32.htm EX-32 8851
  Complete submission text file 0001493152-19-004549.txt   5503966

Data Files

Seq Description Document Type Size
15 XBRL INSTANCE FILE ocx-20181231.xml EX-101.INS 631854
16 XBRL SCHEMA FILE ocx-20181231.xsd EX-101.SCH 49613
17 XBRL CALCULATION FILE ocx-20181231_cal.xml EX-101.CAL 65127
18 XBRL DEFINITION FILE ocx-20181231_def.xml EX-101.DEF 201360
19 XBRL LABEL FILE ocx-20181231_lab.xml EX-101.LAB 385576
20 XBRL PRESENTATION FILE ocx-20181231_pre.xml EX-101.PRE 297156
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37648 | Film No.: 19721305
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences